Health Condition 1: I15- Secondary hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Males and females of age group 18-60 years • Subjects who are willing to give written informed consent • Patient running with Anti Hypertensive drugs or patient having known to be a Hypertensive patient but not yet approached any system of medication. • Diabetic Patient or Patient running with Renal Failure or Patient having Metabolic Syndrome • Female subjects who are confirmed as non-pregnant status and agree to comply with proper contraception throughout the study duration • Patient is willing and able to comply with all trial requirements
Exclusion criteria
Exclusion criteria: • Severe essential hypertension • Significant renal insufficiency [Serum Creatinine > 159 µmol/L ( > 1.8 mg/dl)] • History of cerebro-vascular disease • Patients with a history of HIV infection, AIDS, hepatitis B or C, or other immunosuppressive disorders • Current diagnosis or a history of malignancy • Drug of abuse within the past 2 years • Pregnancy or breastfeeding • Present history of mental diseases • Previous participation in a clinical trial within 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Reduction in DBP & SBP from base line â?¢ Change in mean arterial blood pressure â?¢ Reduction of hypertension related complications over 3 months Timepoint: All visits | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Quality of life SF-36 questionnaire â?¢ Adverse Events recording in all visits. â?¢ Laboratory tests (Haematology, Biochemistry and urine analysis) at base line and post study Timepoint: Pre and post study | — |
Countries
India
Contacts
Natural Solutions